These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 661858)

  • 21. Systolic time interval characteristics in children with Duchenne's progressive muscular dystrophy.
    Sanyal SK; Tierney RC; Rao PS; Pitner SE; George SL; Givins DR
    Pediatrics; 1982 Dec; 70(6):958-64. PubMed ID: 7145553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Double-blind study of the efficacy of an antiserotoninergic drug, pizotifen, in Duchenne's muscular dystrophy].
    Steru D; Paclet JP; Barthelet G; Gailliard G; Piton A; Monchartre E; Roche R; Galli J; Lancrenon S; Fermanian J
    Arch Fr Pediatr; 1987; 44(6):461-5. PubMed ID: 3619586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vital capacity as a prognostic index in Duchenne's muscular dystrophy].
    Dellacasa P; Minetti C; Cordone G
    Minerva Pediatr; 1987 Apr; 39(7):237-9. PubMed ID: 3614146
    [No Abstract]   [Full Text] [Related]  

  • 24. [Steroid treatment of Duchenne's muscular dystrophy].
    Luz Aviles C; Gutiérrez C; Novoa F; Gil E; Stuardo A
    Rev Chil Pediatr; 1982; 53(3):187-91. PubMed ID: 6760264
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cardiomyopathy in Duchenne's muscular dystrophy].
    Rozhold O; Dusek J; Vojácek K; Neoral L
    Vnitr Lek; 1980 Feb; 26(2):182-6. PubMed ID: 7361471
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug trial of superoxide dismutase in Duchenne's muscular dystrophy.
    Stern LZ; Ringel SP; Ziter FA; Menander-Huber KB; Ionasescu V; Pellegrino RJ; Snyder RD
    Arch Neurol; 1982 Jun; 39(6):342-6. PubMed ID: 7046702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allopurinol ineffective in Duchenne muscular dystrophy.
    Bretag AH; Stern LM; Ballard FJ; Tomas FM; Cooper DM; Fewings JD; Goldblatt E
    Lancet; 1981 Jan; 1(8214):276. PubMed ID: 6109925
    [No Abstract]   [Full Text] [Related]  

  • 28. [Duchenne's muscular dystrophy--possible therapy].
    Mortier W
    Monatsschr Kinderheilkd; 1980 Oct; 128(10):673-6. PubMed ID: 6107828
    [No Abstract]   [Full Text] [Related]  

  • 29. [Intelligence deficiency and Duchenne's progressive muscular dystrophy].
    Kayser-Gatchalian MC
    Nervenarzt; 1971 Nov; 42(11):575-9. PubMed ID: 5122912
    [No Abstract]   [Full Text] [Related]  

  • 30. [Lipid peroxidation in children with Duchenne's hereditary myopathy].
    Grinio LP; Orlov ON; Prilipko LL; Kagan VE
    Biull Eksp Biol Med; 1984 Oct; 98(10):423-5. PubMed ID: 6498321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evolution profiles of untreated Duchenne's dystrophy].
    Rideau Y
    Union Med Can; 1979 Jan; 108(1):61, 63-5 68. PubMed ID: 432982
    [No Abstract]   [Full Text] [Related]  

  • 32. Prednisone therapy for Duchenne's muscular dystrophy.
    Brown RH
    N Engl J Med; 1989 Jun; 320(24):1621-3. PubMed ID: 2725603
    [No Abstract]   [Full Text] [Related]  

  • 33. [Composition of erythrocyte phospholipids in Duchenne's muscular dystrophy].
    Beyer P; Bieth R; Robert J; Freysz H; Uhl T
    Ann Pediatr (Paris); 1980 Apr; 27(4):233-6. PubMed ID: 7224543
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiomyopathy in children with Duchenne's progressive muscular dystrophy.
    Sanyal SK; Johnson WW
    Indian Heart J Teach Ser; 1980; (6):258-75. PubMed ID: 7309047
    [No Abstract]   [Full Text] [Related]  

  • 35. Xanthine oxidase inhibitor in Duchenne muscular dystrophy.
    Tamari H; Ohtani Y; Higashi A; Miyoshino S; Matsuda I
    Brain Dev; 1982; 4(2):137-43. PubMed ID: 6896406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allopurinol in Duchenne muscular dystrophy.
    Dubowitz V
    Lancet; 1977 Jan; 1(8005):248-9. PubMed ID: 64767
    [No Abstract]   [Full Text] [Related]  

  • 37. Prednisone therapy for Duchenne's muscular dystrophy.
    Oexle K
    N Engl J Med; 1989 Nov; 321(21):1481-2. PubMed ID: 2811967
    [No Abstract]   [Full Text] [Related]  

  • 38. [Morphological observations in Duchenne's dystrophy].
    Jadro-Santel D; Stancić-Rokotov D; Tjesić-Drinković D
    Neurologija; 1978; 26(1-4):179-87. PubMed ID: 754019
    [No Abstract]   [Full Text] [Related]  

  • 39. Duchenne's muscular dystrophy: the electrocardiogram in female relatives.
    Mann O; DeLeon AC; Perloff JK; Simanis J; Horrigan FD
    Am J Med Sci; 1968 Jun; 255():376-81. PubMed ID: 5654956
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of neuromuscular diseases on the development of dental and occlusal characteristics.
    Ertürk N; Doğan S
    Quintessence Int; 1991 Apr; 22(4):317-21. PubMed ID: 1891607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.